307
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3

, , &
Pages 279-281 | Published online: 23 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier & Suzanne Oparil. (2021) The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug. Blood Pressure 30:6, pages 327-331.
Read now
Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier & Suzanne Oparil. (2018) Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure. Blood Pressure 27:4, pages 185-187.
Read now

Articles from other publishers (4)

Sahib Singh, Amit Rout & Aakash Garg. (2023) Renal denervation in hypertension: An updated meta‐analysis of the randomized controlled trials. Catheterization and Cardiovascular Interventions.
Crossref
Xiaoxv Yang, Hui Liu, Shifang Chen, Pingshuan Dong & Di Zhao. (2022) Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials. Kidney and Blood Pressure Research 47:6, pages 363-374.
Crossref
Peter Sever. (2014) Resistant hypertension and renal denervation: Who’s kidding whom?. Journal of the Renin-Angiotensin-Aldosterone System 15:3, pages 205-208.
Crossref
Fadl Elmula M. Fadl ElmulaPavel HoffmannAnne C. LarstorpEigil FossumMagne BrekkeSverre E. KjeldsenEyvind GjønnæssUlla HjørnholmVibeke N. KjærMorten RostrupIngrid OsAud StenehjemAud Høieggen. (2014) Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant Hypertension. Hypertension 63:5, pages 991-999.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.